{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:23:58Z","timestamp":1792268638343,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7450","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2013,5,23]]},"DOI":"10.1038\/nature12118","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T04:47:15Z","timestamp":1367383635000},"page":"498-502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":401,"title":["The TLR4 antagonist Eritoran protects mice from lethal influenza infection"],"prefix":"10.1038","volume":"497","author":[{"given":"Kari Ann","family":"Shirey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lipsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragnesh","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lioubov M.","family":"Pletneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Karp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"McAlees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa L.","family":"Gioannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbur H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Gusovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge C. G.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie N.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,1]]},"reference":[{"key":"BFnature12118_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","volume":"133","author":"Y Imai","year":"2008","unstructured":"Imai, Y. et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235\u2013249 (2008)","journal-title":"Cell"},{"key":"BFnature12118_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/mi.2009.120","volume":"3","author":"QM Nhu","year":"2010","unstructured":"Nhu, Q. M. et al. Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal Immunol. 3, 29\u201339 (2010)","journal-title":"Mucosal Immunol."},{"key":"BFnature12118_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/SHK.0b013e318227980e","volume":"36","author":"AC Kalil","year":"2011","unstructured":"Kalil, A. C. et al. Influence of severity of illness on the effects of eritoran tetrasodium (E5564) and on other therapies for severe sepsis. Shock 36, 327\u2013331 (2011)","journal-title":"Shock"},{"key":"BFnature12118_CR4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1124\/jpet.102.044487","volume":"304","author":"M Mullarkey","year":"2003","unstructured":"Mullarkey, M. et al. Inhibition of endotoxin response by E5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J. Pharmacol. Exp. Ther. 304, 1093\u20131102 (2003)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnature12118_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.289.2.179","volume":"289","author":"WW Thompson","year":"2003","unstructured":"Thompson, W. W. et al. Mortality associated with influenza and respiratory syncytial virus in the United States. J. Am. Med. Assoc. 289, 179\u2013186 (2003)","journal-title":"J. Am. Med. Assoc."},{"key":"BFnature12118_CR6","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","volume":"292","author":"WW Thompson","year":"2004","unstructured":"Thompson, W. W. et al. Influenza-associated hospitalizations in the United States. J. Am. Med. Assoc. 292, 1333\u20131340 (2004)","journal-title":"J. Am. Med. Assoc."},{"key":"BFnature12118_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1286-4579(00)01351-4","volume":"3","author":"AH Reid","year":"2001","unstructured":"Reid, A. H., Taubenberger, J. K. & Fanning, T. G. The 1918 Spanish influenza: integrating history and biology. Microbes Infect. 3, 81\u201387 (2001)","journal-title":"Microbes Infect."},{"key":"BFnature12118_CR8","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1098\/rstb.2001.1020","volume":"356","author":"JK Taubenberger","year":"2001","unstructured":"Taubenberger, J. K., Reid, A. H., Janczewski, T. A. & Fanning, T. G. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Phil. Trans. R. Soc. Lond. B 356, 1829\u20131839 (2001)","journal-title":"Phil. Trans. R. Soc. Lond. B"},{"key":"BFnature12118_CR9","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1128\/JVI.01200-09","volume":"83","author":"AC Hurt","year":"2009","unstructured":"Hurt, A. C., Holien, J. K., Parker, M., Kelso, A. & Barr, I. G. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J. Virol. 83, 10366\u201310373 (2009)","journal-title":"J. Virol."},{"key":"BFnature12118_CR10","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1128\/JVI.72.3.2456-2462.1998","volume":"72","author":"JL McKimm-Breschkin","year":"1998","unstructured":"McKimm-Breschkin, J. L. et al. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J. Virol. 72, 2456\u20132462 (1998)","journal-title":"J. Virol."},{"key":"BFnature12118_CR11","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1128\/AAC.49.11.4515-4520.2005","volume":"49","author":"VP Mishin","year":"2005","unstructured":"Mishin, V. P., Hayden, F. G. & Gubareva, L. V. Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob. Agents Chemother. 49, 4515\u20134520 (2005)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature12118_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/jcp.1041570103","volume":"157","author":"SE Goldblum","year":"1993","unstructured":"Goldblum, S. E., Ding, X., Brann, T. W. & Campbell-Washington, J. Bacterial lipopolysaccharide induces actin reorganization, intercellular gap formation, and endothelial barrier dysfunction in pulmonary vascular endothelial cells: concurrent F-actin depolymerization and new actin synthesis. J. Cell. Physiol. 157, 13\u201323 (1993)","journal-title":"J. Cell. Physiol."},{"key":"BFnature12118_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.virol.2009.05.004","volume":"390","author":"D Verhoeven","year":"2009","unstructured":"Verhoeven, D., Teijaro, J. T. & Farber, D. L. Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection. Virology 390, 151\u2013156 (2009)","journal-title":"Virology"},{"key":"BFnature12118_CR14","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1128\/JVI.00638-12","volume":"87","author":"JCG Blanco","year":"2013","unstructured":"Blanco, J. C. G. et al. Receptor characterization and suceptibility of cotton rats to avian and 2009 pandemic influenza virus strains. J. Virol. 87, 2036\u20132045 (2013)","journal-title":"J. Virol."},{"key":"BFnature12118_CR15","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1099\/vir.0.81145-0","volume":"86","author":"MG Ottolini","year":"2005","unstructured":"Ottolini, M. G. et al. The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis. J. Gen. Virol. 86, 2823\u20132830 (2005)","journal-title":"J. Gen. Virol."},{"key":"BFnature12118_CR16","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2353\/ajpath.2006.050875","volume":"168","author":"NK Polakos","year":"2006","unstructured":"Polakos, N. K. et al. Kupffer cell-dependent hepatitis occurs during influenza infection. Am. J. Pathol. 168, 1169\u20131178 (2006)","journal-title":"Am. J. Pathol."},{"key":"BFnature12118_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","volume":"3","author":"JK Taubenberger","year":"2008","unstructured":"Taubenberger, J. K. & Morens, D. M. The pathology of influenza virus infections. Annu. Rev. Pathol. 3, 499\u2013522 (2008)","journal-title":"Annu. Rev. Pathol."},{"key":"BFnature12118_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1189\/jlb.0410216","volume":"89","author":"KA Shirey","year":"2011","unstructured":"Shirey, K. A. et al. The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-\u03b2-mediated antiviral activity in vitro and in vivo. J. Leukoc. Biol. 89, 351\u2013357 (2011)","journal-title":"J. Leukoc. Biol."},{"key":"BFnature12118_CR19","doi-asserted-by":"publisher","first-page":"31119","DOI":"10.1074\/jbc.M604958200","volume":"281","author":"KE Thomas","year":"2006","unstructured":"Thomas, K. E., Galligan, C. L., Newman, R. D., Fish, E. N. & Vogel, S. N. Contribution of interferon-\u03b2 to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide. J. Biol. Chem. 281, 31119\u201331130 (2006)","journal-title":"J. Biol. Chem."},{"key":"BFnature12118_CR20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2007.08.002","volume":"130","author":"HM Kim","year":"2007","unstructured":"Kim, H. M. et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran. Cell 130, 906\u2013917 (2007)","journal-title":"Cell"},{"key":"BFnature12118_CR21","doi-asserted-by":"publisher","first-page":"10990","DOI":"10.1073\/pnas.1004153107","volume":"107","author":"SI Yoon","year":"2010","unstructured":"Yoon, S. I., Hong, M., Han, G. W. & Wilson, I. A. Crystal structure of soluble MD-1 and its interaction with lipid IVa. Proc. Natl Acad. Sci. USA 107, 10990\u201310995 (2010)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature12118_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/1753425911422723","volume":"18","author":"GA Esparza","year":"2012","unstructured":"Esparza, G. A., Teghanemt, A., Zhang, D., Gioannini, T. L. & Weiss, J. P. Endotoxin-albumin complexes transfer endotoxin monomers to MD-2 resulting in activation of TLR4. Innate Immun. 18, 478\u2013491 (2012)","journal-title":"Innate Immun."},{"key":"BFnature12118_CR23","doi-asserted-by":"publisher","first-page":"47818","DOI":"10.1074\/jbc.M206404200","volume":"277","author":"TL Gioannini","year":"2002","unstructured":"Gioannini, T. L., Zhang, D., Teghanemt, A. & Weiss, J. P. An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation. J. Biol. Chem. 277, 47818\u201347825 (2002)","journal-title":"J. Biol. Chem."},{"key":"BFnature12118_CR24","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.4049\/jimmunol.163.12.6748","volume":"163","author":"TK Means","year":"1999","unstructured":"Means, T. K. et al. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 163, 6748\u20136755 (1999)","journal-title":"J. Immunol."},{"key":"BFnature12118_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.imbio.2004.04.002","volume":"209","author":"C Pauligk","year":"2004","unstructured":"Pauligk, C., Nain, M., Reiling, N., Gemsa, D. & Kaufmann, A. CD14 is required for influenza A virus-induced cytokine and chemokine production. Immunobiology 209, 3\u201310 (2004)","journal-title":"Immunobiology"},{"key":"BFnature12118_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-3083.2005.01714.x","volume":"63","author":"RM Lee","year":"2006","unstructured":"Lee, R. M., White, M. R. & Hartshorn, K. L. Influenza A viruses upregulate neutrophil Toll-like receptor 2 expression and function. Scand. J. Immunol. 63, 81\u201389 (2006)","journal-title":"Scand. J. Immunol."},{"key":"BFnature12118_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1743-422X-8-97","volume":"8","author":"K Shinya","year":"2011","unstructured":"Shinya, K. et al. Toll-like receptor pre-stimulation protects mice against lethal infection with high pathogenic influenza viruses. Virol. J. 8, 97\u2013101 (2011)","journal-title":"Virol. J."},{"key":"BFnature12118_CR28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1177\/0091270003254804","volume":"43","author":"YN Wong","year":"2003","unstructured":"Wong, Y. N. et al. Safety, pharmacokinetics, and pharmacodynamics of E5564, a lipid A antagonist, during an ascending single-dose clinical study. J. Clin. Pharmacol. 43, 735\u2013742 (2003)","journal-title":"J. Clin. Pharmacol."},{"key":"BFnature12118_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/CCM.0b013e3181b07b78","volume":"38","author":"M Tidswell","year":"2010","unstructured":"Tidswell, M. et al. Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis. Crit. Care Med. 38, 72\u201383 (2010)","journal-title":"Crit. Care Med."},{"key":"BFnature12118_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S1473-3099(12)70136-6","volume":"12","author":"J Cohen","year":"2012","unstructured":"Cohen, J., Opal, S. & Calandra, T. Sepsis studies need new direction. Lancet Infect. Dis. 12, 503\u2013505 (2012)","journal-title":"Lancet Infect. Dis."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature12118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature12118","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature12118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T07:23:23Z","timestamp":1688196203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature12118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,1]]},"references-count":30,"journal-issue":{"issue":"7450","published-print":{"date-parts":[[2013,5,23]]}},"alternative-id":["BFnature12118"],"URL":"https:\/\/doi.org\/10.1038\/nature12118","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718013265.793477352","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,1]]},"assertion":[{"value":"19 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2013","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A minor change was made to the Fig. 4 legend.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"With the exception of F.G., none of the authors have a competing interest. F.G. is an employee of Eisai Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}